LOMELVIA Trademark

Trademark Overview

On Friday, November 30, 2018, a trademark application was filed for LOMELVIA with the United States Patent and Trademark Office. The USPTO has given the LOMELVIA trademark a serial number of 88212381. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 11, 2022. This trademark is owned by Glaxo Group Limited. The LOMELVIA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
lomelvia

General Information

Serial Number88212381
Word MarkLOMELVIA
Filing DateFriday, November 30, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 11, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 9, 2019

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, December 20, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Trademark Events

Event DateEvent Description
Monday, July 11, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, July 11, 2022ABANDONMENT - NO USE STATEMENT FILED
Tuesday, November 2, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 1, 2021SOU EXTENSION 5 GRANTED
Thursday, October 28, 2021SOU EXTENSION 5 FILED
Thursday, October 28, 2021TEAS EXTENSION RECEIVED
Friday, May 14, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 12, 2021SOU EXTENSION 4 GRANTED
Wednesday, May 12, 2021SOU EXTENSION 4 FILED
Wednesday, May 12, 2021TEAS EXTENSION RECEIVED
Tuesday, October 13, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, October 9, 2020SOU EXTENSION 3 GRANTED
Friday, October 9, 2020SOU EXTENSION 3 FILED
Friday, October 9, 2020TEAS EXTENSION RECEIVED
Wednesday, February 26, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 25, 2020SOU EXTENSION 2 GRANTED
Monday, February 17, 2020SOU EXTENSION 2 FILED
Tuesday, February 25, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, February 17, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, February 17, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, February 17, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, February 17, 2020TEAS EXTENSION RECEIVED
Wednesday, November 27, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 25, 2019SOU EXTENSION 1 GRANTED
Monday, November 25, 2019SOU EXTENSION 1 FILED
Monday, November 25, 2019TEAS EXTENSION RECEIVED
Tuesday, June 4, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 9, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 9, 2019PUBLISHED FOR OPPOSITION
Wednesday, March 20, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, March 1, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, March 1, 2019ASSIGNED TO EXAMINER
Thursday, December 20, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, December 4, 2018NEW APPLICATION ENTERED IN TRAM

Related Keywords

lomelvia pharmaceutical treatment preparations diseases disorders substances respiratory oncological genitourinary neurological